Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
345 participants
OBSERVATIONAL
2025-04-22
2025-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact on Mortality of Screening for Kidney Disease Associated With a Specialized Intervention During Hospitalization in a Territorial Hospital Trust
NCT05033652
Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
NCT02938611
Development of a Decision-making Aid for Referring Severe Kidney Injury Patients for Nephrology Consultations
NCT03192189
Screening for Chronic Kidney Disease (CKD) Among Older People Across Europe (SCOPE)
NCT02691546
Chronic Kidney Disease Screening
NCT07153432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic Kidney Disease Group
Patients with chronic kidney disease and at least one referral criterion for nephrology teleconsultation.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Teleconsultation to nephrology from Primary Care in the Garraf region during the period from January to December 2024
* Patients with at least one referral criterion for the nephrology service
Exclusion Criteria
* Patients with Chronic Kidney Disease previously evaluated by the nephrology service.
* History of requiring renal replacement therapy (hemodialysis, peritoneal dialysis, or kidney transplantation).
* Patients hospitalized within the last 3 months with a diagnosis of kidney failure.
* Patients with a known prior diagnosis of Autosomal Dominant Polycystic Kidney Disease or glomerular diseases.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Consorci Sanitari de l'Alt Penedès i Garraf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ignacio Manzur, MD
Role: PRINCIPAL_INVESTIGATOR
CSAPG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Consorci Sanitari Alt Penedés-Garraf
Sant Pere de Ribes, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSAPG-72
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.